Bares Capital Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-450,000
| Closed | -$3.39M | – | 30 |
|
2024
Q1 | $3.39M | Hold |
450,000
| – | – | 0.13% | 31 |
|
2023
Q4 | $4.17M | Sell |
450,000
-250,000
| -36% | -$2.32M | 0.16% | 32 |
|
2023
Q3 | $7.08M | Sell |
700,000
-80,000
| -10% | -$810K | 0.3% | 34 |
|
2023
Q2 | $9.75M | Buy |
780,000
+330,000
| +73% | +$4.13M | 0.34% | 34 |
|
2023
Q1 | $5.25M | Sell |
450,000
-2,400
| -0.5% | -$28K | 0.19% | 39 |
|
2022
Q4 | $4.81M | Hold |
452,400
| – | – | 0.18% | 36 |
|
2022
Q3 | $4.39M | Buy |
452,400
+200,000
| +79% | +$1.94M | 0.17% | 37 |
|
2022
Q2 | $3.66M | Buy |
252,400
+9,553
| +4% | +$138K | 0.13% | 35 |
|
2022
Q1 | $6.35M | Buy |
242,847
+103,542
| +74% | +$2.71M | 0.15% | 35 |
|
2021
Q4 | $5.52M | Hold |
139,305
| – | – | 0.11% | 34 |
|
2021
Q3 | $6.97M | Buy |
+139,305
| New | +$6.97M | 0.13% | 34 |
|